The increasing effectiveness of pharmacological and non-pharmacological treatment of heart failure has contributed to increased life expectancy and lifespan in patients with implantable ...

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...

Your heart's job is to keep your pulse steady to pump blood throughout your body. Sometimes your heart rate is slower when you're relaxing, and sometimes it's faster when you're exercising or stressed ...

REHOVOT, Israel, April 29, 2022 /PRNewswire/ -- Today, Xcardia Innovation Ltd., a private medical device company developing innovative cardiac pacemaker and defibrillator technology, announced the ...

Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up.